Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yoshimi HACHINO"'
Autor:
Misako Fujino, Shinji Kitamura, Hiroshi Imamura, Chika Fujii, Yukako Yasui, Tomono Kishimoto, Yoshimi Hachino, Hiroshi Furukawa, Ryohei Kawabata
Publikováno v:
Esophagus. 8:179-185
Background There is no standard second-line chemotherapy regimen after failure of the standard 5-fluorouracil and cisplatin in the treatment of esophageal cancer. We retrospectively investigated the efficacy and toxicity of combination chemotherapy u
Autor:
Yoshiharu Shono, Shigehumi Morimoto, Kenji Hasegawa, Katsuyoshi Tabuse, Kumiyo Shimidzu, Yoshimi Hachino, Tetuya Horiuchi, Takako Yamaguchi, Kohei Hasegawa, Yurina Masui, Yoshikazu Fujita
Publikováno v:
YAKUGAKU ZASSHI. 128:135-140
We propose an improved method to measure urinary D-glucaric acid (GA), which might be of value as an indirect index of the activity of cytochrome P450 (CYP). This method was about 20 times more sensitive than existing methods. Beer's law was obeyed i
Autor:
Chika, Fujii, Hiroshi, Imamura, Mutsumi, Fukunaga, Shunji, Kamigaki, Yutaka, Kimura, Tomono, Kawase, Ryohei, Kawabata, Misako, Fujino, Chihiro, Iseki, Yoshiko, Hamaguchi, Emiko, Yamamoto, Toshihiko, Ishizaka, Yoshimi, Hachino
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 40(12)
Hand-foot syndrome( HFS) has been reported to be the most common adverse effect of capecitabine, with an incidence of more than 50%. AboundTM, containing β-hydroxy-β-methyl butyric acid( HMB), L-glutamine, and L-arginine is effective in the treatme
Autor:
Chika, Fujii, Hiroshi, Imamura, Tomono, Kawase, Ryohei, Kawabata, Misako, Fujino, Rumi, Sumida, Chihiro, Iseki, Yoshimi, Hachino, Hiroshi, Furukawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(12)
S-1+cisplatin (CDDP) combination therapy is a standard regimen for advanced gastric cancer and is usually administered within the hospital environment. Recently, ambulatory chemotherapy has been applied to treat various cancers. For the realization o
Autor:
Ryohei, Kawabata, Hiroshi, Imamura, Tomono, Kishimoto, Yoshimi, Hachino, Yukako, Yasui, Misako, Fujino, Chika, Fujii, Mutsumi, Fukunaga, Hiroki, Ohzato, Hiroshi, Furukawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(8)
After Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer(ACTS-GC), adjuvant chemotherapy with S-1 is a standard treatment for stage II or III gastric cancer patients. In this study, we retrospectively examined factors that influence the continuity
Autor:
Yuko, Matsushima, Ryohei, Kawabata, Hiroshi, Imamura, Tomono, Kishimoto, Yoshimi, Hachino, Yukako, Yasui, Misako, Fujino, Chika, Fujii, Mutsumi, Fukunaga, Hiroki, Ohzato, Hiroshi, Furukawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(6)
We investigated the efficacy of gastrojejunostomy followed by S-1-based chemotherapy for unresectable gastric cancer with pyloric stenosis. We performed gastrojejunostomy and S-1-based chemotherapy in 14 unresectable gastric cancer patients with gast
Autor:
Chiya, Oshiro, Shunji, Kamigaki, Yukio, Nakamura, Takashi, Arai, Yukie, Kanai, Misako, Fujino, Chika, Fujii, Yoshiko, Hamaguchi, Chihiro, Iseki, Yoshimi, Hachino, Hiroshi, Furukawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(2)
Chemotherapy-induced nausea and vomiting(CINV)is one of the side effects causing significant psychological and physical suffering in patients receiving chemotherapy. Because CINV often impairs patients' quality of life and leads to discontinuation of
Autor:
Misako, Fujino, Chika, Fujii, Hiroshi, Imamura, Tomono, Kishimoto, Ryohei, Kawabata, Rumi, Sumida, Setsuko, Anami, Yoshimi, Hachino, Hiroshi, Furukawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(1)
The S-1(tegafur/gimeracil/oteracil potassium)granule was developed to meet the needs of patients with cancer. Although the choice of the patients was thought to spread by the addition of the new agent type, the recognition of the S-1 granule is still
Autor:
Shigefumi, Morimoto, Ichiro, Matsuura, Yoshiharu, Shono, Tetsuya, Horiuchi, Yumi, Nakajima, Takashi, Miyabe, Yoshimi, Hachino, Kenji, Hasegawa, Kazuyo, Matsuyama, Yoshikazu, Fujita, Katsuyoshi, Tabuse
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 36(7)
Irinotecan hydrochloride (CPT-11) is converted to SN-38 by carboxylesterase, SN-38 is conjugated by UDP-glucuronosyl- transferase (UGT) to SN-38G. Individual differences in enzyme activity influence the efficacy of this anticancer agent and the adver
Autor:
Kohei, Hasegawa, Kumiyo, Shimidzu, Shigehumi, Morimoto, Yoshimi, Hachino, Kenji, Hasegawa, Yoshiharu, Shono, Tetuya, Horiuchi, Katsuyoshi, Tabuse, Yurina, Masui, Takako, Yamaguchi, Yoshikazu, Fujita
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 128(1)
We propose an improved method to measure urinary D-glucaric acid (GA), which might be of value as an indirect index of the activity of cytochrome P450 (CYP). This method was about 20 times more sensitive than existing methods. Beer's law was obeyed i